LHC Group (NASDAQ:LHCG) Upgraded to “Strong-Buy” by BidaskClub

BidaskClub upgraded shares of LHC Group (NASDAQ:LHCG) from a buy rating to a strong-buy rating in a research note released on Friday morning, BidAskClub reports.

Other equities analysts also recently issued research reports about the stock. Royal Bank of Canada upped their price objective on shares of LHC Group to $130.00 and gave the company an outperform rating in a research note on Monday, May 13th. Barclays reissued a hold rating on shares of LHC Group in a research note on Sunday, May 12th. Zacks Investment Research raised shares of LHC Group from a hold rating to a buy rating and set a $130.00 price objective on the stock in a research note on Thursday, June 27th. UBS Group set a $133.00 price objective on shares of LHC Group and gave the company a buy rating in a research note on Friday, May 10th. Finally, Jefferies Financial Group upped their price objective on shares of LHC Group from $125.00 to $130.00 and gave the company a buy rating in a research note on Thursday, May 9th. Three equities research analysts have rated the stock with a hold rating, eight have issued a buy rating and one has issued a strong buy rating to the stock. The stock has a consensus rating of Buy and a consensus target price of $122.70.

Shares of LHCG stock traded up $0.11 during trading hours on Friday, hitting $123.62. The company’s stock had a trading volume of 293,510 shares, compared to its average volume of 235,941. The stock has a fifty day moving average of $120.83. The firm has a market capitalization of $3.89 billion, a PE ratio of 34.82, a price-to-earnings-growth ratio of 2.10 and a beta of 0.84. LHC Group has a twelve month low of $80.84 and a twelve month high of $129.37. The company has a current ratio of 1.57, a quick ratio of 1.57 and a debt-to-equity ratio of 0.21.

LHC Group (NASDAQ:LHCG) last released its quarterly earnings results on Wednesday, May 8th. The health services provider reported $0.98 EPS for the quarter, beating the consensus estimate of $0.90 by $0.08. The business had revenue of $502.59 million for the quarter, compared to analyst estimates of $511.16 million. LHC Group had a net margin of 3.83% and a return on equity of 8.43%. On average, analysts anticipate that LHC Group will post 4.3 earnings per share for the current fiscal year.

In other LHC Group news, COO Donald Dwayne Stelly sold 3,306 shares of the stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $115.87, for a total transaction of $383,066.22. Following the transaction, the chief operating officer now owns 98,267 shares of the company’s stock, valued at $11,386,197.29. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director John L. Indest sold 30,515 shares of the stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $113.76, for a total transaction of $3,471,386.40. Following the transaction, the director now directly owns 22,947 shares in the company, valued at approximately $2,610,450.72. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 46,269 shares of company stock worth $5,314,613. 5.20% of the stock is currently owned by insiders.

A number of large investors have recently bought and sold shares of the business. Squarepoint Ops LLC purchased a new stake in shares of LHC Group in the fourth quarter worth about $349,000. Amalgamated Bank lifted its position in shares of LHC Group by 128.4% in the fourth quarter. Amalgamated Bank now owns 4,610 shares of the health services provider’s stock worth $433,000 after buying an additional 2,592 shares in the last quarter. FMR LLC increased its stake in LHC Group by 24.9% during the fourth quarter. FMR LLC now owns 1,123,833 shares of the health services provider’s stock worth $105,506,000 after acquiring an additional 224,124 shares during the last quarter. Norges Bank bought a new stake in LHC Group during the fourth quarter worth approximately $51,535,000. Finally, Geode Capital Management LLC increased its stake in LHC Group by 6.7% during the fourth quarter. Geode Capital Management LLC now owns 325,548 shares of the health services provider’s stock worth $30,562,000 after acquiring an additional 20,482 shares during the last quarter. 91.59% of the stock is currently owned by institutional investors.

About LHC Group

LHC Group, Inc provides post-acute health care services to patients through its home nursing agencies, hospices and long-term acute care hospitals. The company operates through the following business segments: Home Health Services, Hospice Services, Home & Community-Based Services, Facility-Based Services and Healthcare Innovations.

Recommended Story: Momentum Indicator: Relative Strength Index

Analyst Recommendations for LHC Group (NASDAQ:LHCG)

Receive News & Ratings for LHC Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LHC Group and related companies with MarketBeat.com's FREE daily email newsletter.